Somatropin Injection — FDA Drug Shortage

To Be Discontinued — Novo Nordisk, Inc.

The FDA lists a drug shortage record for Somatropin Injection (injection) from Novo Nordisk, Inc. with status To Be Discontinued. The shortage was first posted on Nov 14, 2025.

Shortage details

Status
To Be Discontinued
Company
Novo Nordisk, Inc.
Package NDC
0169-7703-21
Dosage Form
Injection
Presentation
Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21)
Initial Posting
Nov 14, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.